Dompé
Pre-clinicalDompé advances research on rhNGF, its biotech pipeline and Exscalate to develop ophthalmic therapies and innovative technologies for clinicians.
Founded
1940
Employees
11-50
Focus
BiologicsSmall MoleculesCell & Gene Therapy
About
Dompé advances research on rhNGF, its biotech pipeline and Exscalate to develop ophthalmic therapies and innovative technologies for clinicians.
Funding History
2Total raised: $35M
Grant$5MEuropean CommissionMar 15, 2020
Series A$30MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded1940
Employees11-50
LocationMilan, Italy
StagePre-clinical
Contact
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile